Key result
CRISPR-mediated nt5 gene mutation in S. aureus enhanced tolerance to daptomycin but weakened bacterial virulence and reduced kidney abscess formation in mice.
Why the study?
Antibiotic resistance in S. aureus is increasingly serious, and the role of the nt5 gene encoding 5’-nucleotidase in drug resistance and infection was nearly unknown.
Does nt5 gene mutation affect daptomycin resistance and virulence in Staphylococcus aureus?
Does nt5 gene mutation affect daptomycin resistance and virulence in Staphylococcus aureus?
Inactivation of the nt5 gene in S. aureus confers tolerance to daptomycin but reduces bacterial virulence and kidney abscess formation, suggesting NT5 as a potential therapeutic target.
May inform adjunctive targets against DAP-resistant S. aureus; leaves open clinical validation of nt5.
The resistance of commonly used clinical antibiotics, such as daptomycin (DAP), has become increasingly serious in the fight against Staphylococcus aureus (S. aureus) infection. It is essential to explore key pathogenicity-driven genes/proteins in bacterial infection and antibiotics resistance, which contributes to develop novel therapeutic strategies against S. aureus infections. The nt5 gene of S. aureus, encoding 5’-nucleotidase (NT5), is nearly unknown for its function in drug resistance and bacterial infection. Herein, to reveal nt5 gene role in drug resistance and infection ability of S. aureus, we performed nt5C166T gene mutation using a clustered regulatory interspaced short palindromic repeat ribonucleic acid (RNA)-guided base editing system to investigate the lose-of-function of NT5 protein. Subsequent transcriptome sequencing of the mutant strain revealed that nt5 inactivation caused changes in cell membrane integrity and inhibited nucleotide metabolism, suggesting the nt5 gene may be involved in bacterial drug resistance and virulence. The mutant strain exhibited enhanced tolerance to DAP treatment by attenuating cell membrane potential dissipation and slowing deoxyribonucleic acid release. Moreover, the nt5 mutation alleviated abscess degree of mouse kidneys caused by S. aureus infection byreducing the expression of IL-1β, IL-6, and IL-18. The nt5 mutant strain was easily swallowed by host immune cells, resulting in weak bacterial toxicity of the S. aureus mutant in the bacterial infection process. In summary, nt5 gene mutation confers tolerance to DAP and a lower bacterial capacity to form kidney abscesses through phagocytosis of host immune cells, which indicates the targeted inhibition of NT5 protein would offer a potential new therapeutic strategy against S. aureus infection.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied Staphylococcus aureus infection. nt5 gene mutation (nt5C166T) via CRISPR RNA-guided base editing was evaluated on Bacterial virulence, immune evasion, and daptomycin tolerance. CRISPR-mediated nt5 gene mutation in S. aureus enhanced tolerance to daptomycin but weakened bacterial virulence and reduced kidney abscess formation in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: